Fulgent Genetics (FLGT) announced it has received CE certification under the European Union’s In Vitro Diagnostic Regulation 2017/746 for its germline next-generation sequencing system, which includes FulgentExome and Fulgent Pipeline Manager. Based on available information, Fulgent may be the first laboratory to receive CE mark for one of the most comprehensive end-to-end germline testing offerings, with more than 4600 genes validated for diagnostic use.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks